120
edits
Changes
Renal Cell Neoplasia Tables: Recurrent Cytogenomic Alterations (view source)
Revision as of 22:50, 14 January 2021
, 22:50, 14 January 2021added footer
|[12, 76, 102, 103, 105, 129, 132, 135-137, 140, 178-180]
|[12, 76, 102, 103, 105, 129, 132, 135-137, 140, 178-180]
|}
|}
Note: <sup>a</sup> level of evidence (ranges from level 1 to 3 as specified in the methods). Level 1, established clinical significance and present in current WHO classification and/or professional practice guidelines such as NCCN, ASCO, CAP guidelines or FDA approval; Level 2, recurrent clinical significance based on large studies with outcomes; and Level 3, recurrent but uncertain clinical significance based on smaller studies and multiple case reports.
<sup>b</sup> clinical significance, D-diagnosis, P-prognosis, R-recurrence
<sup>c</sup> alterations in combination